Javier Trigo

631 total citations
10 papers, 273 citations indexed

About

Javier Trigo is a scholar working on Neurology, Infectious Diseases and Clinical Psychology. According to data from OpenAlex, Javier Trigo has authored 10 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 4 papers in Infectious Diseases and 4 papers in Clinical Psychology. Recurrent topics in Javier Trigo's work include Long-Term Effects of COVID-19 (7 papers), COVID-19 and Mental Health (4 papers) and COVID-19 Clinical Research Studies (4 papers). Javier Trigo is often cited by papers focused on Long-Term Effects of COVID-19 (7 papers), COVID-19 and Mental Health (4 papers) and COVID-19 Clinical Research Studies (4 papers). Javier Trigo collaborates with scholars based in Spain. Javier Trigo's co-authors include David García‐Azorín, Ángel L. Guerrero, Álvaro Sierra, Enrique Martínez‐Pías, Juan F. Arenillas, Blanca Talavera, Álvaro Planchuelo‐Gómez, Mercedes de Lera, Gonzalo Valle‐Peñacoba and Alba Chavarría‐Miranda and has published in prestigious journals such as Journal of the Neurological Sciences, Headache The Journal of Head and Face Pain and Cephalalgia.

In The Last Decade

Javier Trigo

10 papers receiving 271 citations

Peers

Javier Trigo
Javier Trigo
Citations per year, relative to Javier Trigo Javier Trigo (= 1×) peers Blanca Talavera

Countries citing papers authored by Javier Trigo

Since Specialization
Citations

This map shows the geographic impact of Javier Trigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Trigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Trigo more than expected).

Fields of papers citing papers by Javier Trigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Trigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Trigo. The network helps show where Javier Trigo may publish in the future.

Co-authorship network of co-authors of Javier Trigo

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Trigo. A scholar is included among the top collaborators of Javier Trigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Trigo. Javier Trigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Trigo, Javier, David García‐Azorín, Álvaro Tamayo-Velasco, et al.. (2021). Cytokine and interleukin profile in patients with headache and COVID-19: A pilot, CASE-control, study on 104 patients. The Journal of Headache and Pain. 22(1). 51–51. 34 indexed citations
2.
García‐Azorín, David, Javier Trigo, Enrique Martínez‐Pías, et al.. (2021). Neurological symptoms in Covid‐19 patients in the emergency department. Brain and Behavior. 11(4). e02058–e02058. 5 indexed citations
3.
Martínez‐Pías, Enrique, Ángel L. Guerrero, Álvaro Sierra, Javier Trigo, & David García‐Azorín. (2021). Daily Headache in Chronic Migraine Is a Predictive Factor of Response in Patients Who Had Completed Three Sessions of OnabotulinumtoxinA. Toxins. 13(6). 432–432. 3 indexed citations
4.
García‐Azorín, David, Javier Trigo, Blanca Talavera, et al.. (2020). Frequency and Type of Red Flags in Patients With Covid‐19 and Headache: A Series of 104 Hospitalized Patients. Headache The Journal of Head and Face Pain. 60(8). 1664–1672. 32 indexed citations
5.
Sierra, Álvaro, David García‐Azorín, Javier Trigo, et al.. (2020). Clinical characterization of headache attributed to COVID-19: A series of 457 cases. Cephalalgia. 40. 10–10. 1 indexed citations
6.
Talavera, Blanca, David García‐Azorín, Enrique Martínez‐Pías, et al.. (2020). Anosmia is associated with lower in-hospital mortality in COVID-19. Journal of the Neurological Sciences. 419. 117163–117163. 59 indexed citations
7.
Trigo, Javier, David García‐Azorín, Álvaro Planchuelo‐Gómez, et al.. (2020). Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study. The Journal of Headache and Pain. 21(1). 94–94. 98 indexed citations
8.
Planchuelo‐Gómez, Álvaro, Javier Trigo, Rodrigo de Luis‐García, et al.. (2020). Deep Phenotyping of Headache in Hospitalized COVID-19 Patients via Principal Component Analysis. Frontiers in Neurology. 11. 583870–583870. 25 indexed citations
9.
Martínez‐Pías, Enrique, David García‐Azorín, Ane Mínguez‐Olaondo, et al.. (2020). Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients. Expert Review of Neurotherapeutics. 21(1). 123–130. 3 indexed citations
10.
Trigo, Javier, et al.. (2019). Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study. The Journal of Headache and Pain. 20(1). 34–34. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026